Harbourvest Partners’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $343K | Hold |
|
|||||
|
2021
Q3 | $403K | Hold |
|
|||||
|
2021
Q2 | $501K | Hold |
|
|||||
|
2021
Q1 | $612K | Hold |
|
|||||
|
2020
Q4 | $519K | Hold |
|
|||||
|
2020
Q3 | $527K | Hold |
|
|||||
|
2020
Q2 | $660K | Hold |
|
|||||
|
2020
Q1 | $607K | Hold |
|
|||||
|
2019
Q4 | $658K | Hold |
|
|||||
|
2019
Q3 | $584K | Hold |
|
|||||
|
2019
Q2 | $889K | Hold |
|
|||||
|
2019
Q1 | $851K | Hold |
|
|||||
|
2018
Q4 | $1.2M | Hold |
|
|||||
|
2018
Q3 | $1.43M | Hold |
|
|||||
|
2018
Q2 | $1.81M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $608K | Buy |
|
|||||
|
2017
Q1 | $432K | Buy |
|
|||||
|
2016
Q4 | $110K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $102K | Buy |
|